BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24810160)

  • 1. Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior.
    Chien CY; Tsai HT; Su LJ; Chuang HC; Shiu LY; Huang CC; Fang FM; Yu CC; Su HT; Chen CH
    Oncotarget; 2014 Apr; 5(8):2243-62. PubMed ID: 24810160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
    Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pairing a prognostic target with potential therapeutic strategy for head and neck cancer.
    Lek SM; Li K; Tan QX; Shannon NB; Ng WH; Hendrikson J; Tan JWS; Lim HJ; Chen Y; Koh KKN; Skanthakumar T; Kwang XL; Chong FT; Leong HS; Tay G; Putri NE; Lim TKH; Hwang JSG; Ang MK; Tan DSW; Tan NC; Tan HK; Kon OL; Soo KC; Iyer NG; Ong CJ
    Oral Oncol; 2020 Dec; 111():105035. PubMed ID: 33091845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
    Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
    J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer.
    Chen CH; Chang AY; Li SH; Tsai HT; Shiu LY; Su LJ; Wang WL; Chiu TJ; Luo SD; Huang TL; Chien CY
    Mol Cancer; 2015 Apr; 14():83. PubMed ID: 25889801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
    Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
    Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurora kinase A inhibition and paclitaxel as targeted combination therapy for head and neck squamous cell carcinoma.
    Mazumdar A; Henderson YC; El-Naggar AK; Sen S; Clayman GL
    Head Neck; 2009 May; 31(5):625-34. PubMed ID: 19107951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of p21-activated kinase-1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer.
    Park J; Kim JM; Park JK; Huang S; Kwak SY; Ryu KA; Kong G; Park J; Koo BS
    Head Neck; 2015 Jul; 37(7):953-63. PubMed ID: 24634274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway.
    Chen CH; Shiu LY; Su LJ; Huang CY; Huang SC; Huang CC; Yin YF; Wang WS; Tsai HT; Fang FM; Chuang WC; Kang HC; Hwang CF
    J Transl Med; 2012 May; 10():93. PubMed ID: 22591637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of neutrophil gelatinase-associated lipocalin in head and neck squamous cell carcinoma correlated with tumorigenesis, not with metastasis.
    Wang L; Chen C; Li F; Hua Q; Chen S; Xiao B; Dai M; Li M; Zheng A; Yu D; Hu Z; Tao Z
    Int J Clin Exp Pathol; 2015; 8(8):8857-68. PubMed ID: 26464627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
    Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
    Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of leucine zipper-EF-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma.
    Chen L; Yang Y; Liu S; Piao L; Zhang Y; Lin Z; Li Z
    Biomed Res Int; 2014; 2014():850316. PubMed ID: 24689060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancer.
    Sharpe DJ; Orr KS; Moran M; White SJ; McQuaid S; Lappin TR; Thompson A; James JA
    Oncotarget; 2014 Sep; 5(18):8803-15. PubMed ID: 25301728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocyte chemotactic protein 1 (MCP-1) modulates pro-survival signaling to promote progression of head and neck squamous cell carcinoma.
    Ji WT; Chen HR; Lin CH; Lee JW; Lee CC
    PLoS One; 2014; 9(2):e88952. PubMed ID: 24586454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma.
    Takikita M; Xie R; Chung JY; Cho H; Ylaya K; Hong SM; Moskaluk CA; Hewitt SM
    J Transl Med; 2011 Jul; 9():126. PubMed ID: 21801427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.
    Celetti A; Testa D; Staibano S; Merolla F; Guarino V; Castellone MD; Iovine R; Mansueto G; Somma P; De Rosa G; Galli V; Melillo RM; Santoro M
    Clin Cancer Res; 2005 Nov; 11(22):8019-27. PubMed ID: 16299231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NM23-H1 expression of head and neck squamous cell carcinoma in association with the response to cisplatin treatment.
    Wang YF; Chang CJ; Chiu JH; Lin CP; Li WY; Chang SY; Chu PY; Tai SK; Chen YJ
    Oncotarget; 2014 Sep; 5(17):7392-405. PubMed ID: 25277180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
    Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
    Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
    Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion.
    Rao VH; Kandel A; Lynch D; Pena Z; Marwaha N; Deng C; Watson P; Hansen LA
    Oncogene; 2012 Jun; 31(23):2888-98. PubMed ID: 21986939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.